| abstract |
An azaaryl derivative having the structure of formula (I), a process for its preparation and its use in pharmacy. The series of compounds of the invention can be widely applied to the preparation of drugs for treating cancer, tumor, autoimmune disease, metabolic disease or metastatic disease, especially for treating ovarian cancer, pancreatic cancer, prostate cancer, breast cancer, cervical cancer, gelatinous Drugs for cell tumors, multiple myeloma, metabolic diseases, neurodegenerative diseases, metastatic tumor sites or bone metastatic cancers are expected to be developed into a new generation of CSF1R inhibitor drugs. |